We are focusing this issue on the growing body of independent research on our electrically heated tobacco product (EHTP, marketed as IQOS), the most advanced smoke-free alternative in our portfolio. The covered research comprises independent, peer-reviewed publications on smoke-free products that focus on EHTP, and also includes four recent government reports from the UK, the US, Germany, and the Netherlands. Other sections include an update on the assessment of each product in our smoke-free portfolio, recent R&D milestones and a compendium of PMI’s peer-reviewed publications on its smoke-free products this year.
“We are happy to see growing interest in studying our smoke-free products and that the general trend among independent results is in line with our own research,” said Prof. Manuel Peitsch, PMI’s Chief Scientific Officer. “Independent research on our electronically heated tobacco product, ETHP, demonstrates significant improvements relative to cigarettes, and is crucial to our efforts to change the lives of millions of smokers around the world.”
PMI’s extensive research and assessment program is inspired by the well-recognized practices of the pharmaceutical industry and in line with the draft guidance of the U.S. FDA for Modified Risk Tobacco Product (MRTP) Applications. PMI employs over 400 world-class scientists, engineers and experts in a variety of research and development disciplines, and has published over 250 scientific publications in peer-reviewed journal and book chapters on smoke-free products.
Philip Morris International: Who We Are
We are a leading international tobacco company engaged in the manufacture and sale of cigarettes and other nicotine-containing products in markets outside the United States of America. We’re building our future on smoke-free products that are a much better choice than continuing to smoke cigarettes. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, we aim to ensure that our smoke-free products meet adult consumer preferences and rigorous regulatory requirements. Our vision is that these products ultimately replace cigarettes to the benefit of adult smokers, society, our company and our shareholders. For more information, see our PMI and PMIScience websites.
